Concepedia

Bo Luo

BL

Statistics

Publications

7

Citations

104

H-Index

7

Active since

2022

Affiliations

Huazhong University of Science and Technology(Current)

Hubei Cancer Hospital

Bo Luo is an author at Huazhong University of Science and Technology specializing in molecular oncology, pi3k signaling, and cancer signaling pathways.

ORCID

Publications per year

2022–2024

7

Publications

7

Overexpression of HMGB3 and its prognostic value in breast cancer

Xiaomei Zhou, Qu Zhang, Gai Liang et al. · Frontiers in Oncology · 2022 · 20 citations · Full text

, , +17

Transcription factor HOXB2 upregulates NUSAP1 to promote the proliferation, invasion and migration of nephroblastoma cells via the PI3K/Akt signaling pathway

Bo Luo, Shasha Feng, Tianliang Li et al. · Molecular Medicine Reports · 2022 · 18 citations · Full text

, , +14

Targeted Delivery of Gemcitabine for Precision Therapy of Cholangiocarcinoma Using Hyaluronic Acid-Modified Metal–Organic Framework Nanoparticles

Chuan Long, Han Peng, Wei Yang et al. · ACS Omega · 2024 · 15 citations · Full text

, , +17

Gallic Acid Alleviates Cognitive Impairment by Promoting Neurogenesis via the GSK3β-Nrf2 Signaling Pathway in an APP/PS1 Mouse Model

Yu Ding, Jinrong He, Fanli Kong et al. · Journal of Alzheimer s Disease Reports · 2024 · 14 citations · Full text

, , +17

Dynamic changes in human THP-1-derived M1-to-M2 macrophage polarization during Thelazia callipaeda MIF induction

Changzhu Yin, Juan Cai, Yan-Ting Gou et al. · Frontiers in Immunology · 2023 · 13 citations · Full text

, , +17

1–5 of 7